Viemed Healthcare (VMD) president logs RSU vesting and tax-share sales

Rhea-AI Filing Summary

Viemed Healthcare President Michael Moore reported equity award vesting and related share movements. On January 21, 2026, 34,214 Restricted Stock Units (RSUs) were converted into an equal number of common shares, and 8,554 phantom share units under the company’s Phantom Share Unit Plan vested, each economically equivalent to one common share.

To cover taxes from RSU vesting, 9,358 common shares were withheld by Viemed Healthcare at a per share value of $7.49, and 8,554 common shares related to the phantom share settlement were disposed of to the company at the same value. After these transactions, Moore directly held 169,590 common shares, 68,428 RSUs and 17,107 phantom share units, and also had an indirect interest in 1,722,614 common shares held by Moore Faster LLC.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moore Michael

(Last) (First) (Middle)

625 E. KALISTE SALOOM RD.

(Street)

LAFAYETTE LA 70508

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
01/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	01/21/2026		M		34,214	A	(1)	178,948	D
Common Shares	01/21/2026		F		9,358(2)	D	$7.49(3)	169,590	D
Common Shares	01/21/2026		M		8,554	A	(4)	178,144	D
Common Shares	01/21/2026		D		8,554	D	$7.49(3)	169,590	D
Common Shares								1,722,614	I	by Moore Faster LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	01/21/2026		M			34,214	(5)	01/21/2028	Common Shares	34,214	$0	68,428	D
Phantom Share Units	(4)	01/21/2026		M			8,554	(6)	01/21/2028	Common Shares	8,554	(4)	17,107	D

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

2. Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.

3. Per share value is based on the market closing price of the common shares for January 21, 2026.

4. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.

5. Restricted Stock Units (RSUs) granted to reporting person on January 21, 2025, which vest in three equal annual installments beginning on the first anniversary of the grant date.

6. Represents an award granted on January 21, 2025 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.

Remarks:

	/s/ Jesse Bergeron, Attorney-in-Fact	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Viemed Healthcare (VMD) report for Michael Moore?

The filing shows that President Michael Moore had 34,214 RSUs and 8,554 phantom share units vest on January 21, 2026, which were settled into common shares with related share dispositions to the company and tax withholding.

How many Viemed Healthcare (VMD) common shares does Michael Moore hold after this Form 4?

After the reported transactions, Michael Moore directly held 169,590 common shares and had an indirect interest in 1,722,614 common shares held by Moore Faster LLC.

What happened to Michael Moore’s Viemed RSUs and phantom share units on January 21, 2026?

On January 21, 2026, 34,214 RSUs and 8,554 phantom share units vested, each representing the economic equivalent of one common share. These were exchanged for common shares, with some of those shares then delivered back to the company for cash.

Why were some of Michael Moore’s Viemed Healthcare shares withheld or disposed of?

The filing states that 9,358 shares were withheld to satisfy tax obligations arising from RSU vesting, and 8,554 shares tied to phantom share units were disposed of to the company for cash as part of settling those cash-settled awards.

What prices were used for Michael Moore’s Viemed Healthcare share withholdings and dispositions?

The per share value for the 9,358 withheld shares and the 8,554 disposed shares is reported as $7.49, based on the market closing price of Viemed’s common shares on January 21, 2026.

What derivative holdings does Michael Moore have in Viemed Healthcare after these transactions?

Following the transactions, Michael Moore held 68,428 RSUs and 17,107 phantom share units, each ultimately tied to Viemed Healthcare common shares under their respective plans.